By amplifying this campaign, you encourage lawmakers to increase patent access to safe, effective and affordable generic and biosimilar medicines.
Be a Part of the Conversation
Be sure to bookmark www.doesntaddup.com and follow the Association for Accessible Medicines’ social media accounts. You can find @AccessibleMeds and @BiosimsCouncil on Twitter. We are also on Facebook, Instagram and LinkedIn and will be posting updates on this campaign and releasing new data and resources.
Social Media
Share the message and the movement with all those in your own social networks. Tweet and post your own messages about the need for Congress to address these market challenges so patients can stop paying outrageous prices for their prescription medicines. You can also retweet other messages you find with the hashtag #DoesntAddUp.
Here are some sample messages
and images to use in social media:
Even though generic drug prices have been going down, patients like us are still paying more. Tell Congress that #DoesntAddUp. Learn more at: https://www.doesntaddup.com
Our out-of-pocket costs shouldn’t go up when generic prices go down. That #DoesntAddUp. Tell Congress to act: https://www.doesntaddup.com
In the past four years, Medicare patients like me paid $22 billion more than we needed to for generics. That #DoesntAddUp. Congress can take action! https://www.doesntaddup.com
Even though the FDA is approving so many generics to be the first to compete with brands, fewer than half make it to the market—and only half of those are available to Medicare patients like me. This just #DoesntAddUp. Congress can help. Learn more at: https://www.doesntaddup.com
Biosimilars hold great promise to be more affordable alternatives to expensive biologic medicines, but only 11 of 24 FDA-approved biosimilars are available to U.S. patients. It #DoesntAddUp. Congress can help. Learn more at: https://www.doesntaddup.com
In the past four years, Medicare patients overpaid by $22 billion for generic medicines. That #DoesntAddUp. Learn how Congress can take action now. https://www.doesntaddup.com
Even though generic drug prices have been going down, patients like us are still paying more. Tell Congress that #DoesntAddUp. Learn more at: https://www.doesntaddup.com
Even though the FDA is approving so many generics to be the first to compete with brands, fewer than half make it to the market—and only half of those are available to Medicare patients like me. This just #DoesntAddUp. Congress can help. Learn more at: https://www.doesntaddup.com
In the past four years, Medicare patients overpaid by $22 billion for generic medicines. That #DoesntAddUp. Learn how Congress can take action now. https://www.doesntaddup.com
Stay Up To Date
Stay informed about legislation that affects your access to affordable generic and biosimilar medicines. Check out our AAM Action Center for additional advocacy campaigns.
